Fangzhou Inc. Honored as an "Outstanding Innovation Firm" by Yangcheng Evening News

December 27, 2024 08:30 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

GUANGZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored as an "Outstanding Innovation Firm" at the "Precision Engineering: 2024 Technology Pioneers Gala" held by Yangcheng Evening News on December 13th. Fangzhou garnered recognition for its significant milestones in 2024, including a successful listing on the Main Board of the Hong Kong Stock Exchange, and its role in spearheading the ongoing digital transformation of China's healthcare sector.

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, remarked, "We are thrilled to receive this award from Yangcheng Evening News as an 'Outstanding Innovation Firm'. Adhering to our corporate mission of 'Better Health for All', we will continue to cultivate a bold vision for the future of the Internet healthcare sector."

2024 has been a significant year in Fangzhou's development journey. Following its IPO in July 2024, the Company received commendation from the Guangzhou Municipal People's Government for its contributions in advancing the digital transformation of the healthcare industry and enhancing public health. In October, Fangzhou was featured on the 2024 Guangdong "AI Catalyst" Enterprise Billboard at the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. More recently, the Company launched its " AI Agent Solution" in November 2024 in partnership with Tencent Healthcare and Baidu Health, providing more efficient access to healthcare information and analysis for both consumers and healthcare professionals.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About Yangcheng Evening News

Yangcheng Evening News, first published in October 1957, was among the first broadly distributed evening newspapers established after the founding of People's Republic of China. Produced in Guangzhou as the flagship publication of the Yangcheng Evening News Group, the newspaper has built a strong reputation for its critical and independent perspective, delivering engaging news coverage on a variety of topics that resonate with people's daily lives.

Media Contact

For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: [email protected] 

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.